HEADER MEMBRANE PROTEIN 17-APR-22 7ZLY TITLE CRYSTAL STRUCTURE OF HUMAN GPCR NIACIN RECEPTOR (HCA2) EXPRESSED FROM TITLE 2 SPODOPTERA FRUGIPERDA COMPND MOL_ID: 1; COMPND 2 MOLECULE: HYDROXYCARBOXYLIC ACID RECEPTOR 2,SOLUBLE CYTOCHROME B562; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: G-PROTEIN COUPLED RECEPTOR 109A,G-PROTEIN COUPLED RECEPTOR COMPND 5 HM74A,NIACIN RECEPTOR 1,NICOTINIC ACID RECEPTOR,CYTOCHROME B-562; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ESCHERICHIA COLI; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 562; SOURCE 5 GENE: HCAR2, GPR109A, HCA2, HM74A, NIACR1, CYBC; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS NIACIN RECEPTOR, HYDROXYCARBOXYLIC ACID RECEPTOR 2, HCA2, GPCR, KEYWDS 2 MEMBRANE PROTEIN STRUCTURE, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.YANG,H.J.KANG,R.G.GAO,J.J.WANG,J.F.FIBERTO,L.J.WU,J.H.TONG,G.W.HAN, AUTHOR 2 L.QU,Y.R.WU,R.PILESKI,X.M.LI,X.C.ZHANG,S.W.ZHAO,T.KENAKIN,Q.WANG, AUTHOR 3 R.C.STEVENS,W.PENG,B.L.ROTH,Z.H.RAO,Z.J.LIU REVDAT 2 07-FEB-24 7ZLY 1 REMARK REVDAT 1 12-APR-23 7ZLY 0 JRNL AUTH Y.YANG,H.J.KANG,R.GAO,J.WANG,G.W.HAN,J.F.DIBERTO,L.WU, JRNL AUTH 2 J.TONG,L.QU,Y.WU,R.PILESKI,X.LI,X.C.ZHANG,S.ZHAO,T.KENAKIN, JRNL AUTH 3 Q.WANG,R.C.STEVENS,W.PENG,B.L.ROTH,Z.RAO,Z.J.LIU JRNL TITL STRUCTURAL INSIGHTS INTO THE HUMAN NIACIN RECEPTOR HCA2-G I JRNL TITL 2 SIGNALLING COMPLEX. JRNL REF NAT COMMUN V. 14 1692 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 36973264 JRNL DOI 10.1038/S41467-023-37177-6 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.97 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 3 NUMBER OF REFLECTIONS : 25559 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.250 REMARK 3 FREE R VALUE : 0.280 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : NULL REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3088 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 94 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7ZLY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1292122447. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-NOV-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL41XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25559 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 47.972 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.1800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.75 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4PXZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM PH5.4 SODIUM CITRATE, 60MM REMARK 280 AMMONIUM CITRATE, 36% PEG400, AND 3% ADDITIVE 80 (40% PPG), REMARK 280 LIPIDIC CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,-Y,-Z+1/2 REMARK 290 4555 -X+1/2,-Y,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 40.54000 REMARK 290 SMTRY2 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.15500 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 40.54000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 43.15500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2450 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19870 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASN A 2 REMARK 465 ARG A 3 REMARK 465 HIS A 4 REMARK 465 HIS A 5 REMARK 465 LEU A 6 REMARK 465 GLN A 7 REMARK 465 ASP A 8 REMARK 465 HIS A 9 REMARK 465 PHE A 10 REMARK 465 GLY A 172 REMARK 465 GLY A 173 REMARK 465 PRO A 265 REMARK 465 LYS A 266 REMARK 465 LEU A 267 REMARK 465 GLU A 268 REMARK 465 ASP A 269 REMARK 465 LYS A 270 REMARK 465 SER A 271 REMARK 465 PRO A 272 REMARK 465 ASP A 273 REMARK 465 SER A 274 REMARK 465 PRO A 275 REMARK 465 GLU A 276 REMARK 465 LEU A 419 REMARK 465 GLN A 420 REMARK 465 ARG A 421 REMARK 465 LYS A 422 REMARK 465 MET A 423 REMARK 465 THR A 424 REMARK 465 GLY A 425 REMARK 465 GLU A 426 REMARK 465 PRO A 427 REMARK 465 ASP A 428 REMARK 465 ASN A 429 REMARK 465 ASN A 430 REMARK 465 ARG A 431 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 13 CG1 CG2 CD1 REMARK 470 ASP A 14 CG OD1 OD2 REMARK 470 LYS A 15 CG CD CE NZ REMARK 470 LYS A 16 CG CD CE NZ REMARK 470 ASN A 17 CG OD1 ND2 REMARK 470 LYS A 28 CG CD CE NZ REMARK 470 LYS A 57 CG CD CE NZ REMARK 470 LYS A 60 CG CD CE NZ REMARK 470 LYS A 94 CG CD CE NZ REMARK 470 LYS A 164 CG CD CE NZ REMARK 470 LYS A 165 CG CD CE NZ REMARK 470 LYS A 166 CG CD CE NZ REMARK 470 GLN A 170 CG CD OE1 NE2 REMARK 470 ASN A 171 CG OD1 ND2 REMARK 470 LYS A 234 CG CD CE NZ REMARK 470 LYS A 238 CG CD CE NZ REMARK 470 LYS A 251 CG CD CE NZ REMARK 470 LYS A 261 CG CD CE NZ REMARK 470 MET A 277 CG SD CE REMARK 470 LYS A 278 CG CD CE NZ REMARK 470 ASP A 279 CG OD1 OD2 REMARK 470 PHE A 280 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 281 CG CD NE CZ NH1 NH2 REMARK 470 HIS A 282 CG ND1 CD2 CE1 NE2 REMARK 470 LEU A 297 CG CD1 CD2 REMARK 470 LYS A 302 CG CD CE NZ REMARK 470 LYS A 304 CG CD CE NZ REMARK 470 GLU A 305 CG CD OE1 OE2 REMARK 470 GLN A 312 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 17 70.23 56.94 REMARK 500 PHE A 180 82.66 -66.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OLA A 501 REMARK 610 OLA A 503 REMARK 610 OLA A 504 REMARK 610 OLA A 505 REMARK 610 OLA A 506 DBREF 7ZLY A 1 219 UNP Q8TDS4 HCAR2_HUMAN 1 219 DBREF 7ZLY A 220 324 UNP P0ABE7 C562_ECOLX 23 127 DBREF 7ZLY A 326 431 UNP Q8TDS4 HCAR2_HUMAN 220 325 SEQADV 7ZLY VAL A 70 UNP Q8TDS4 ALA 70 CONFLICT SEQADV 7ZLY TRP A 226 UNP P0ABE7 MET 29 CONFLICT SEQADV 7ZLY ILE A 321 UNP P0ABE7 HIS 124 CONFLICT SEQADV 7ZLY LEU A 325 UNP P0ABE7 LINKER SEQADV 7ZLY VAL A 393 UNP Q8TDS4 SER 287 CONFLICT SEQRES 1 A 431 MET ASN ARG HIS HIS LEU GLN ASP HIS PHE LEU GLU ILE SEQRES 2 A 431 ASP LYS LYS ASN CYS CYS VAL PHE ARG ASP ASP PHE ILE SEQRES 3 A 431 VAL LYS VAL LEU PRO PRO VAL LEU GLY LEU GLU PHE ILE SEQRES 4 A 431 PHE GLY LEU LEU GLY ASN GLY LEU ALA LEU TRP ILE PHE SEQRES 5 A 431 CYS PHE HIS LEU LYS SER TRP LYS SER SER ARG ILE PHE SEQRES 6 A 431 LEU PHE ASN LEU VAL VAL ALA ASP PHE LEU LEU ILE ILE SEQRES 7 A 431 CYS LEU PRO PHE LEU MET ASP ASN TYR VAL ARG ARG TRP SEQRES 8 A 431 ASP TRP LYS PHE GLY ASP ILE PRO CYS ARG LEU MET LEU SEQRES 9 A 431 PHE MET LEU ALA MET ASN ARG GLN GLY SER ILE ILE PHE SEQRES 10 A 431 LEU THR VAL VAL ALA VAL ASP ARG TYR PHE ARG VAL VAL SEQRES 11 A 431 HIS PRO HIS HIS ALA LEU ASN LYS ILE SER ASN ARG THR SEQRES 12 A 431 ALA ALA ILE ILE SER CYS LEU LEU TRP GLY ILE THR ILE SEQRES 13 A 431 GLY LEU THR VAL HIS LEU LEU LYS LYS LYS MET PRO ILE SEQRES 14 A 431 GLN ASN GLY GLY ALA ASN LEU CYS SER SER PHE SER ILE SEQRES 15 A 431 CYS HIS THR PHE GLN TRP HIS GLU ALA MET PHE LEU LEU SEQRES 16 A 431 GLU PHE PHE LEU PRO LEU GLY ILE ILE LEU PHE CYS SER SEQRES 17 A 431 ALA ARG ILE ILE TRP SER LEU ARG GLN ARG GLN ALA ASP SEQRES 18 A 431 LEU GLU ASP ASN TRP GLU THR LEU ASN ASP ASN LEU LYS SEQRES 19 A 431 VAL ILE GLU LYS ALA ASP ASN ALA ALA GLN VAL LYS ASP SEQRES 20 A 431 ALA LEU THR LYS MET ARG ALA ALA ALA LEU ASP ALA GLN SEQRES 21 A 431 LYS ALA THR PRO PRO LYS LEU GLU ASP LYS SER PRO ASP SEQRES 22 A 431 SER PRO GLU MET LYS ASP PHE ARG HIS GLY PHE ASP ILE SEQRES 23 A 431 LEU VAL GLY GLN ILE ASP ASP ALA LEU LYS LEU ALA ASN SEQRES 24 A 431 GLU GLY LYS VAL LYS GLU ALA GLN ALA ALA ALA GLU GLN SEQRES 25 A 431 LEU LYS THR THR ARG ASN ALA TYR ILE GLN LYS TYR LEU SEQRES 26 A 431 MET ASP ARG HIS ALA LYS ILE LYS ARG ALA ILE THR PHE SEQRES 27 A 431 ILE MET VAL VAL ALA ILE VAL PHE VAL ILE CYS PHE LEU SEQRES 28 A 431 PRO SER VAL VAL VAL ARG ILE ARG ILE PHE TRP LEU LEU SEQRES 29 A 431 HIS THR SER GLY THR GLN ASN CYS GLU VAL TYR ARG SER SEQRES 30 A 431 VAL ASP LEU ALA PHE PHE ILE THR LEU SER PHE THR TYR SEQRES 31 A 431 MET ASN VAL MET LEU ASP PRO VAL VAL TYR TYR PHE SER SEQRES 32 A 431 SER PRO SER PHE PRO ASN PHE PHE SER THR LEU ILE ASN SEQRES 33 A 431 ARG CYS LEU GLN ARG LYS MET THR GLY GLU PRO ASP ASN SEQRES 34 A 431 ASN ARG HET OLA A 501 11 HET OLA A 502 20 HET OLA A 503 7 HET OLA A 504 7 HET OLA A 505 8 HET OLA A 506 16 HET OLC A 507 25 HETNAM OLA OLEIC ACID HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETSYN OLC 1-OLEOYL-R-GLYCEROL FORMUL 2 OLA 6(C18 H34 O2) FORMUL 8 OLC C21 H40 O4 HELIX 1 AA1 ASP A 23 PHE A 54 1 32 HELIX 2 AA2 LYS A 60 ARG A 89 1 30 HELIX 3 AA3 GLY A 96 VAL A 130 1 35 HELIX 4 AA4 HIS A 134 ILE A 139 5 6 HELIX 5 AA5 SER A 140 VAL A 160 1 21 HELIX 6 AA6 HIS A 161 LYS A 164 5 4 HELIX 7 AA7 GLN A 187 LYS A 238 1 52 HELIX 8 AA8 ALA A 243 THR A 263 1 21 HELIX 9 AA9 LYS A 278 GLU A 300 1 23 HELIX 10 AB1 LYS A 302 ALA A 310 1 9 HELIX 11 AB2 GLU A 311 ILE A 321 1 11 HELIX 12 AB3 ILE A 321 SER A 367 1 47 HELIX 13 AB4 ASN A 371 VAL A 374 5 4 HELIX 14 AB5 TYR A 375 TYR A 390 1 16 HELIX 15 AB6 MET A 391 PHE A 402 1 12 HELIX 16 AB7 PRO A 405 ARG A 417 1 13 SHEET 1 AA1 2 ILE A 13 ASP A 14 0 SHEET 2 AA1 2 CYS A 18 CYS A 19 -1 O CYS A 18 N ASP A 14 SSBOND 1 CYS A 18 CYS A 183 1555 1555 2.03 SSBOND 2 CYS A 19 CYS A 372 1555 1555 2.03 SSBOND 3 CYS A 100 CYS A 177 1555 1555 2.03 CISPEP 1 MET A 167 PRO A 168 0 -4.61 CRYST1 81.080 82.150 86.310 90.00 90.00 90.00 P 21 2 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012333 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012173 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011586 0.00000